BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 23886956)

  • 21. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment.
    Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S
    Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Zhang X; Li L; Chen S; Yang D; Wang Y; Zhang X; Wang Z; Le W
    Autophagy; 2011 Apr; 7(4):412-25. PubMed ID: 21193837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
    Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
    Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of chaperone activity is a shared property of several Cu,Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis.
    Tummala H; Jung C; Tiwari A; Higgins CM; Hayward LJ; Xu Z
    J Biol Chem; 2005 May; 280(18):17725-31. PubMed ID: 15753080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
    King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
    Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal cells but not muscle cells are resistant to oxidative stress mediated protein misfolding and cell death: role of molecular chaperones.
    Bhattacharya A; Wei R; Hamilton RT; Chaudhuri AR
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1250-4. PubMed ID: 24685484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1
    Mallozzi C; Spalloni A; Longone P; Domenici MR
    Neural Plast; 2018; 2018():2430193. PubMed ID: 30154836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
    Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
    Meister S; Storck SE; Hameister E; Behl C; Weggen S; Clement AM; Pietrzik CU
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1112-21. PubMed ID: 25853911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
    Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
    Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
    Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention.
    Tradewell ML; Cooper LA; Minotti S; Durham HD
    Neurobiol Dis; 2011 Jun; 42(3):265-75. PubMed ID: 21296666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
    Turner BJ; Parkinson NJ; Davies KE; Talbot K
    Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice.
    Maatkamp A; Vlug A; Haasdijk E; Troost D; French PJ; Jaarsma D
    Eur J Neurosci; 2004 Jul; 20(1):14-28. PubMed ID: 15245475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.